About Emergent Bioservices
We are the Bioservices (CDMO) division of Emergent BioSolutions (NYSE: EBS), a biopharmaceutical company dedicated to protecting and enhancing lives.
Emergent BioSolutions specializes in confronting — and combating — the most serious intentional and natural threats to public health, including anthrax, Ebola, smallpox, botulism, and opioid addiction. The company has been proud to serve as a leading provider of antiviral, antimicrobial, and hyperimmune products for the United States and a host of other nations for over two decades.
So while the Emergent brand may be best-known as the maker of products like BioThrax® vaccine and NARCAN® nasal spray, our Bioservices clients have come to rely on our capabilities, resources, and unique experience to manufacture their live-saving, life-enhancing products.